About us
On a mission to help
The MSBase Foundation aims to advance collaborative epidemiological and outcomes research by providing a freely accessible resource to combine, compare and analyse large datasets, for the benefit of people with multiple sclerosis and other neuro-immunological diseases.
Membership
Join our mission.
Make your impact.
Neurologists, take part by joining a collaboration dedicated to making a difference to the lives of patients with MS and other neuro-immunological diseases.
MSBase has served as a unique resource on the quest of translating data into evidence. Alongside large national registries and high-quality cohorts, it has enabled us to generate new knowledge, which has been guiding the use of disease modifying therapies across ages, multiple sclerosis phenotypes, including over the long term and in scenarios that can not be studied in randomised trials. It has provided us with an instrumental data-space to apply, adopt or develop rigorous analytical methods. I am excited to see MSBase apply the learned experience beyond multiple sclerosis, in the research of rarer neuroimmunological diseases.
Prof Tomas Kalincik, Australia
MSBase has been real a pioneer in the field of MS to answer numerous clinical questions that we face every day in practice, by collecting and analyzing real-world data. It’s exciting that MSBase is expanding to other neuroimmunological diseases such as NMOSD and MOGAD. The inclusiveness and reach of this global network are key-strengths to perform world-wide collaborative studies resulting in excellent joint publications that have made a highly relevant impact on clinical care for people with MS.
Barbara Willekens, Belgium
MSBase gave us the unique possibility to showcase some innovative proof-of-concepts using cutting edge technologies like artificial intelligence and federated learning. In doing so, MSBase confirms their pioneering role in the real-world MS data ecosystem.
Liesbet M. Peeters, Belgium
MSBase provided me with a well-developed evolving platform for scientific research in collaboration with international, well-recognised Multiple Sclerosis experts.
Dr Raed Alroughani, Kuwait
To become a member of MSBase opened many research opportunities to my centre – Hospital de S. Joao - the only portuguese center entering the registry up to now. iMed is very important, we access it in each consultation to see the patient’s evolution and alert to eventual redflags. To be aware how our local cohort compares with the MSBase whole registry is very reassuring and a relevant issue of this collaborative research.
Maria Jose Sa, Portugal
Latest news
Follow us
Our sponsors & donors
